# Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

> **NCT00203034** · PHASE3 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 472 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** rasagiline mesylate
- **DRUG:** 1.0 mg rasagiline mesylate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00203034
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2003-01
- **Final completion:** 2003-01
- **Target enrollment:** 472 (ACTUAL)
- **Last updated:** 2010-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00203034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00203034, "Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00203034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*